News

Recursion Pharmaceuticals (RXRX) Jumps 31% On Next-Gen AI
We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...
Business Wire6y
Recursion Releases Open-Source Data from Largest Ever Dataset of Biological Images, Inviting Data Science Community to Develop New and Improved Machine Learning Algorithms for ...
At more than two petabytes, and across more than 10 million different biological contexts, Recursion’s data is the world’s largest image-based dataset designed specifically for the development ...
Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT
Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, ...
Seeking Alpha1y
Revisiting Recursion: Big Bets, Big Data, And The Big Cash Burn Rate
Recursion Pharmaceuticals uses ... Despite the vast amounts of data generated by the biopharma industry, the structures were not designed with machine learning in mind. The problem isn't just ...
TechCrunch7y
Drug discovery startup Recursion raises $60 million in Series B from Data Collective
Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B round, led by Data Collective ... Instead, it uses that image-based approach to look at ...
Yahoo Finance1y
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced two ...